Video

Complementary Therapy and Exercise in Patients With MPNs

Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).

Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).

Even on standard MPN therapy, such as JAK inhibitors, many patients will still have residual issues, such as fatigue and itching, so complementary therapies may be of help. Currently, Mesa’s team is investigating the effectiveness of such therapies. Meanwhile, physical activity has been known to improve quality of life in patients undergoing cancer treatment. However, it is important that patients don’t overdo it and get the approval of their health care team before starting a new workout regimen.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Image of Staci.
Image of woman, with text.
Image of woman with text.
Related Content